Latest Articles

Publication Date
Can Anticancer Drugs Be A Promising Candidate for The Treatment of Endometriosis?

Endometriosis, a benign gynecological disorder affecting 10-15% of women during their reproductive years, is characterized by the growth of endometrial tissue outside the uterus. Despite its prevalence, the exact pathophysiology …

Published: Feb. 23, 2025, midnight
Primary Low-Grade Endometrial Stromal Sarcoma of the Ovary Arising From Endometriosis: A Case Report.

Low-grade endometrial stromal sarcoma (LGESS) is a rare mesenchymal tumor of female genital tract malignancies. While it primarily arises in the uterus, extrauterine cases, including those originating in the ovary, …

Published: Feb. 23, 2025, midnight
Ananda Pharma's MRX1 moves closer to clinical trials - ICYMI - Proactive Investors UK

Ananda Pharma's MRX1 moves closer to clinical trials - ICYMI Proactive Investors UK

Published: Feb. 22, 2025, 5:05 a.m.
'I'm a nutritionist and this one superfood can help fix your hormones' - The Mirror

'I'm a nutritionist and this one superfood can help fix your hormones' The Mirror

Published: Feb. 22, 2025, 4:35 a.m.
A quality-of-life meta-analysis comparing pre- and postoperative symptoms in women undergoing colorectal resection for deep infiltrating endometriosis.

Deep infiltrating endometriosis (DIE) may involve the rectum or colon and is associated with pain, gastrointestinal dysfunction and reduced quality of life (QoL). While hormonal treatment may be effective, surgical …

Published: Feb. 22, 2025, 12:15 a.m.
A large-scale genome-wide association study on female genital tract polyps highlights role of DNA repair, cell proliferation, and cell growth.

Can a large-scale genome-wide association study (GWAS) meta-analysis identify genomic risk loci and likely involved genes for female genital tract (FGT) polyps, provide insights into the biological mechanism underlying their …

Published: Feb. 22, 2025, midnight
Binnopharm to compete with global drugmakers in Russian hormonal drugs market - The Pharma Letter

Binnopharm to compete with global drugmakers in Russian hormonal drugs market The Pharma Letter

Published: Feb. 21, 2025, 3:09 p.m.
Karyopharm targets $1B revenue potential for Selinexor in myelofibrosis amid Phase 3 progress - MSN

Karyopharm targets $1B revenue potential for Selinexor in myelofibrosis amid Phase 3 progress MSN

Published: Feb. 21, 2025, 12:07 p.m.
Analyzing the association between menstrual coitus and endometriosis' pathogenesis: A narrative review.

Across studies, the percentage of individuals reporting regularly engaging in menstrual coitus ranges between 4% and 43%. Although no clinical guideline recommends avoiding sexual activity during menstruation, according to some …

Published: Feb. 21, 2025, 12:26 a.m.
Serum neurofilament light chain levels in patients with small-fiber neuropathy.

Serum neurofilament light chain (sNfL) levels are an increasingly employed tool for the assessment of active axonal injury in a variety of neurological disorders including polyneuropathy. Injury to the small …

Published: Feb. 21, 2025, 12:04 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!